Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535264-25-000028
Filing Date
2025-05-07
Accepted
2025-05-07 14:52:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7279
  Complete submission text file 0001535264-25-000028.txt   9267
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Subject) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-54715 | Film No.: 25920828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022
Business Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022 212-319-6670
AWM Investment Company, Inc. (Filed by) CIK: 0001535264 (see all company filings)

EIN.: 113086452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G